Technical Support
(877) SEPAX-US, press 3      
TechSupport@sepax-tech.com

Representative Literature References

Click a row to open its literature reference.
Product PN Seperation Mode
Broad Sample Type Specific Sample
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   Next   View All
Year Product PN Sep. Mode Broad Sample Category Specific Sample Title
2013Zenix SEC-300N/ASECADCN/ATrastuzumab-Doxorubicin Conjugate Provides Enhanced Anti-Cancer Potency and Reduced Cardiotoxicity
Journal of Cancer Therapy, Vol.4 No.1
2012Zenix SEC-300N/ASECProteinN/AAccurate retention time determination of co-eluting proteins in analytical chromatography by means of spectral data
Biotechnology and Bioengineering, Volume 110, Issue 3, pages 683-693,
2011Zenix SEC-300N/ASECAntibodyN/AAntibody solubility behavior in monovalent salt solutions reveals specific anion effects at low ionic strength
Journal of Pharmaceutical Sciences, Volume 101, Issue 3, pages 965-977
2012Zenix SEC-300N/ASECAntibodyN/AAglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system
mAbs, Volume 4, Issue 2, pages 217-225
2012Zenix SEC-300N/ASECProteinN/ARapid quantification of protein–polyethylene glycol conjugates by multivariate evaluation of chromatographic data
Journal of Chromatography A, Volume 1257, Pages 41-47
2013SRT SEC-300N/ASECMembrane ProteinN/AThe rhodopsin-transducin complex houses two distinct rhodopsin molecules
Journal of Structural Biology, Volume 182, Issue 2, Pages 164-172
2013SRT SEC-300N/ASECFc Fusion ProteinN/ACharacterization of Fc-fusion protein aggregates derived from extracellular domain disulfide bond rearrangements
Journal of Pharmaceutical Sciences, Volume 102, Issue 2, pages 441-453
2013SRT SEC-300N/ASECMembrane ProteinN/ASteroid-based facial amphiphiles for stabilization and crystallization of membrane proteins
PNAS, vol. 110 no. 13
2013Zenix SEC-300N/ASECBispecific AntibodyN/AKnobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity
MAbs, 5(6), 872-81
2013Zenix SEC-300N/ASECPEG/PEGylated ProteinN/AOptimization of random PEGylation reactions by means of high throughput screening
Biotechnology and Bioengineering, Volume 111, Issue 1, pages 104-114
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   Next   View All
© 2020 Sepax Technologies, Inc. All Rights Reserved.